Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Jeroen Verheijen"'
Autor:
Arie Zask, Pawel Nowak, Robert T. Abraham, James J. Gibbons, Tarek S. Mansour, Semiramis Ayral-Kaloustian, John Ellingboe, Derek C. Cole, David J. Malwitz, Kevin Curran, Jeroen Verheijen, Jamie Kim, Boris Shor, Judy Lucas, Wei-Guo Zhang, Celine Shi, Lourdes Toral-Barza, Ker Yu
Supplementary Methods, Figures 1-2, Tables 1-2 from Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5af9a5271aa0276274bef18b48d37d
https://doi.org/10.1158/0008-5472.22378673.v1
https://doi.org/10.1158/0008-5472.22378673.v1
Autor:
Jose Alcantara, Kenneth Kulmatycki, David J. Rowlands, Nicholas J. Simmonds, Lidia Mostovy, Surendra Machineni, Ivan Bottoli, Phaninatha Sarma Ayalavajjala, Robert M. Strieter, Henry Danahay, Shamsah Kazani, Raju Vegesna, Jerry A. Nick, Ieuan Jones, Mohammed Salman, Steven M. Rowe, Ian Nicholls, Martin Gosling, Julie Milojevic, Jeroen Verheijen
Publikováno v:
Journal of Cystic Fibrosis. 20:250-256
Background This is the first-in-human study of icenticaftor, an oral potentiator of the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) channel. Restoration of CFTR activity has shown significant clinical benefits, but more studies ar